phosphoramidate pronucleotide (GlaxoSmithKline)

N/A

Report date: 2025/03/20 14:38:26
NME

Base Information

Drug Namephosphoramidate pronucleotide (GlaxoSmithKline)
Drug Alias Namenucleoside reverse transcriptase inhibitors (GlaxoSmithkline)ABCpro
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A